India Approves Compulsory License Allowing Generic Copy of Patented Drug
The Indian Patent Office approved its first compulsory license application, authorizing the Natco Pharma to sell a generic copy of Bayer’s patented drug Nexavar at a price of Rs 8,880 ($175) for a month’s supply. Bayer currently charges over Rs 2.8 lakh... Read More